Treating Rare Endocrine Disorders with Therapeutic Peptides

Mark Sumeray, chief medical officer of Amolyt, discusses what it’s like for people living with the hypoparathyroidism, why it is difficult to manage with current medical approaches, and why therapeutic peptides offer a compelling approach for hypothyroidism and other endocrine disorders.